NIDA to showcase PEERx teen initiative at National RX Drug Abuse Summit

A unique, new campaign targeting teens will be on exhibit at the first national summit addressing the prescription drug abuse epidemic. The National Institute on Drug Abuse (NIDA) will showcase "PEERx," a NIDA initiative that uses interactive videos and other tools to educate teens about the dangers of prescription drug abuse and help them to spread the word. Teen leaders from SADD (Students Against Destructive Decisions) will assist NIDA in exhibiting PEERx and hosting a train-the-trainer workshop for state and national leaders, law enforcement officials, medical professionals, community advocates, treatment experts, educators, private industry leaders, and others attending the event.

NIDA's involvement in the national summit also includes an exhibit for NIDAMED, a collection of tools and resources to assist health care providers in detecting drug abuse early, preventing escalation to addiction, and referring patients to treatment when necessary.

WHO: National Institute on Drug Abuse (NIDA)
Teens from Students Against Destructive Decisions (SADD)

WHAT: NIDA's PEERx campaign for teens

WHEN: April 10, 2012: 11:00 a.m. to 7:00 p.m. EDT (Train-the-Trainer: 1:00-2:00 p.m.)
April 11, 2012: 7 a.m. to 5 p.m. EDT

WHERE: National RX Drug Abuse Summit
Walt Disney World Swan Resort
1200 Epcot Resorts Boulevard
Lake Buena Vista, Florida

Source: NIH/National Institute on Drug Abuse

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Medicare coverage for obesity drug raises questions